Effect of docetaxel and carboplatin combined with radical cervical cancer in the treatment of cervical cancer and the influence of serum tumor markers and cytokines
10.3760/cma.j.cn115807-20230902-00074
- VernacularTitle:多西他赛+卡铂联合宫颈癌根治术治疗宫颈癌疗效及对血清肿瘤标志物和细胞免疫因子的影响
- Author:
Tiandi LIU
1
;
Qing LI
;
Wei JI
Author Information
1. 西北妇女儿童医院妇科，西安 710061
- Keywords:
Docetaxel;
Carboplatin;
Cervical cancer;
Chemotherapy;
Tumor markers;
Immune function
- From:
Chinese Journal of Endocrine Surgery
2024;18(3):429-433
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the effects of docetaxel, Carboplatin combined with radical cervical cancer surgery on the expression of serum tumor markers and Th1/Th2 cytokines in patients with cervical cancer.Methods:96 patients with cervical cancer from Aug. 2018 to Aug. 2020 were selected as the study subjects. They were randomly divided into operation group and chemotherapy + operation group according to random number table method. Surgical group underwent radical hysterectomy (laparoscopic hysterectomy + pelvic lymph node dissection), chemotherapy + surgery group received docetaxel + Carboplatin adjuvant chemotherapy before operation. Serum tumor markers [CEA, CA125, CA19-9, squamous epithelium fine] were compared between the two groups. The expression of SCC, Th1/Th 2 cytokines [IFN-gamma, IL-2, IL-4, IL-6] and the occurrence of bone marrow suppression were evaluated.Results:There was no significant difference in serum CEA, CA125, CA19-9 or SCC between the two groups before treatment ( P>0.05), but they were significantly decreased after treatment ( P<0.05). After treatment, IFN-γ [ (20.58±3.52) ; (25.69±3.61) ] and IL-2 [ (24.68±4.46) ; (29.53±5.28) ] were significantly increased in the two groups ( P<0.05). IL-4 [ (17.65±4.12) ; (13.59±4.23) ] and IL-6 [ (24.59±3.85) (31.76±4.42) ] were significantly decreased ( P<0.05). IFN-γ and IL-2 in the acupuncture group were significantly higher than those in the operation group ( P<0.05). IL-4 and IL-6 were significantly lower than those in the operation group ( P<0.05), and serum CEA [ (33.89±5.51) ng/L; (30.46±4.86) ng/L], CA125, CA19-9 [ (42.21±5.23) U/mL; (37.56±5.61) U/mL] and SCC [ (1.12±0.12) μg/mL; (0.96±0.15) μg/mL] were significantly decreased ( P<0.05). The chemotherapy group was significantly lower than the surgery group ( P<0.05), and the effective rate of chemotherapy group was significantly higher than that of the operation group ( P<0.05), and there was no significant difference in myelosuppression between the two groups ( P>0.05) . Conclusion:Docetaxel plus Carboplatin adjuvant chemotherapy before radical operation of cervical cancer can significantly improve the clinical efficacy, reduce the level of serum tumor markers, improve immune function, and do not increase adverse reactions. It is worth promoting.
